Inventor
REARDAN DAYTON T
US36 patents
⚠️ This page may combine multiple inventors who share the name “REARDAN DAYTON T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XOMA CORP
7 patentsUS5090914AFeb 25, 1992
Activated polymers and conjugates thereof
XOMA CORP29 citations92
US5081295AJan 14, 1992
Activated polyers and conjugates thereof
XOMA CORP20 citations82
US5157099AOct 20, 1992
Activated polymers and conjugates thereof
XOMA CORP11 citations74
US5103039AApr 7, 1992
Activated polymers and conjugates thereof
XOMA CORP18 citations74
US4970303ANov 13, 1990
Linking agents and methods
XOMA CORP12 citations74
US5218112AJun 8, 1993
Linking agents and methods
XOMA CORP3 citations63
US5221771AJun 22, 1993
Activated polymers and conjugates thereof
XOMA CORP0 citations52
JAZZ PHARMACEUTICALS INC
4 patentsUS9539330B2Jan 10, 2017
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
JAZZ PHARMACEUTICALS INC67 citations98
US8952062B2Feb 10, 2015
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
JAZZ PHARMACEUTICALS INC97 citations98
US8859619B2Oct 14, 2014
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
JAZZ PHARMACEUTICALS INC82 citations98
US7895059B2Feb 22, 2011
Sensitive drug distribution system and method
JAZZ PHARMACEUTICALS INC113 citations98
JPI COMMERCIAL LLC
4 patentsUS7797171B2Sep 14, 2010
Sensitive drug distribution system and method
JPI COMMERCIAL LLC116 citations98
US7765106B2Jul 27, 2010
Sensitive drug distribution system and method
JPI COMMERCIAL LLC119 citations98
US7765107B2Jul 27, 2010
Sensitive drug distribution system and method
JPI COMMERCIAL LLC117 citations98
US7668730B2Feb 23, 2010
Sensitive drug distribution system and method
JPI COMMERCIAL LLC144 citations95
QOL MEDICAL LLC
4 patentsUS9255261B2Feb 9, 2016
Ultrapure hypoallergenic solutions of sacrosidase
QOL MEDICAL LLC3 citations69
US9849161B2Dec 26, 2017
Ultrapure hypoallergenic solutions of sacrosidase
QOL MEDICAL LLC1 citations59
US9469847B2Oct 18, 2016
Ultrapure hypoallergenic solutions of sacrosidase
QOL MEDICAL LLC2 citations59
US10588947B2Mar 17, 2020
Ultrapure hypoallergenic solutions of sacrosidase
QOL MEDICAL LLC0 citations48
COOK HARRY
3 patentsUS8461203B2Jun 11, 2013
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
COOK HARRY83 citations98
US8324275B2Dec 4, 2012
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
COOK HARRY109 citations98
US8263650B2Sep 11, 2012
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
COOK HARRY136 citations98
REARDAN DAYTON T
3 patentsNiche Biopharmaceuticals LLC
3 patentsUS11572342B2Feb 7, 2023
Antimicrobial and antiviral sulfur containing glycerol monoester derivatives
Niche Biopharmaceuticals LLC1 citations69
US11365176B2Jun 21, 2022
Antimicrobial and antiviral sulfur containing glycerol monoester derivatives
Niche Biopharmaceuticals LLC2 citations69
US11873272B2Jan 16, 2024
Antimicrobial and antiviral sulfur containing glycerol monoester derivatives
Niche Biopharmaceuticals LLC0 citations58
CV THERAPEUTICS INC
3 patentsUS7071174B1Jul 4, 2006
Method and composition for inhibiting cholesterol esterase
CV THERAPEUTICS INC2 citations62
US5521303AMay 28, 1996
Method of manufacturing non-absorbable synthetic sulfated polysaccharides
CV THERAPEUTICS INC4 citations62
US6632801B1Oct 14, 2003
Method and composition for inhibiting human cholesterol esterase
CV THERAPEUTICS INC1 citations52